UNILAB, Inc., a leading pharmaceutical company based in the Philippines, has been a cornerstone of the healthcare industry since its establishment in 1945. Headquartered in Quezon City, UNILAB operates extensively across the Philippines and has a growing presence in various international markets. Specialising in the development, manufacturing, and distribution of high-quality pharmaceutical products, UNILAB offers a diverse portfolio that includes prescription medications, over-the-counter drugs, and consumer health products. What sets UNILAB apart is its commitment to innovation and quality, ensuring that its offerings meet the highest standards of safety and efficacy. With a strong market position, UNILAB has achieved numerous accolades, solidifying its reputation as a trusted name in healthcare. The company continues to lead the way in addressing the evolving needs of patients and healthcare professionals alike.
How does UNILAB, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
UNILAB, Inc.'s score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
UNILAB, Inc., headquartered in the Philippines, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that UNILAB, Inc. may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As such, the company appears to be in the early stages of addressing climate-related impacts within its operations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
UNILAB, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
